Difference between revisions of "Dermagraft-TC"

From IntactiWiki
Jump to navigation Jump to search
m
(Wikify.)
 
(9 intermediate revisions by one other user not shown)
Line 1: Line 1:
 
[[Image:Dermagraft.png|right|thumb|]]
 
[[Image:Dermagraft.png|right|thumb|]]
Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb
+
'''Dermagraft-TC''' is an artifical [[skin]] created from harvested [[foreskin| foreskins]] from infant [[circumcision]].<ref name='Advanced Biohealing, 2010'>{{REFweb
  | quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
+
  |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
  | url=http://www.dermagraft.com/about/overview/
+
  |url=http://www.dermagraft.com/about/overview/
  | title=Dermagraft-TC: Overview
+
  |title=Dermagraft-TC: Overview
  | last=
+
  |last=
  | first=
+
  |first=
  | publisher=Advanced Biohealing, Inc.
+
  |publisher=Advanced Biohealing, Inc.
  | work=
+
  |website=
  | date=
+
  |date=
  | accessdate=2011-03-06
+
  |accessdate=2011-03-06
}}</ref> It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb
+
}}</ref> It is made and sold by [[Advanced Tissue Sciences]] (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb
  | quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
+
  |quote=...fibroblast-derived temporary [[skin]] substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
  | url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation
+
  |url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation
  | title=Dermagraft-TC
+
  |title=Dermagraft-TC
  | last=
+
  |last=
  | first=
+
  |first=
  | publisher=MediLexicon
+
  |publisher=MediLexicon
  | work=
+
  |website=
  | date=
+
  |date=
  | accessdate=2011-03-06
+
  |accessdate=2011-03-06
 
}}</ref><ref name='Transplant News 2007-03-28'>{{REFnews
 
}}</ref><ref name='Transplant News 2007-03-28'>{{REFnews
  | last=
+
  |last=
  | first=
+
  |first=
| coauthors=
+
  |url=http://www.highbeam.com/doc/1G1-47248437.html
  | url=http://www.highbeam.com/doc/1G1-47248437.html
+
  |title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA
  | title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA
+
  |date=2007-03-28
  | date=2007-03-28
+
  |publisher=Transplant News
  | publisher=Transplant News
+
  |quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary [[skin]] substitute to be approved.
  | quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
+
  |accessdate=2011-03-06
  | accessdate=2011-03-06
+
}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of [[skin]].<ref>{{REFjournal
}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>Circumcision. Daecher M. Icon 1998;2(2):70-3.</ref>
+
|last=Daecher
 +
|init=M
 +
|title=Circumcision
 +
|journal=Icon
 +
|date=1998
 +
|volume=2
 +
|issue=2
 +
|pages=70-73
 +
|url=
 +
|quote=
 +
|pubmedID=
 +
|pubmedCID=
 +
|DOI=
 +
|accessdate=
 +
}}</ref>
  
 
{{REF}}
 
{{REF}}
  
[[Category:Foreskin Products]]
+
[[Category:Foreskin product]]
[[Category:Financial Gain]]
+
[[Category:Financial gain]]
  
 
[[Category:From CircLeaks]]
 
[[Category:From CircLeaks]]
 
[[Category:From IntactWiki]]
 
[[Category:From IntactWiki]]
 +
 +
[[de:{{FULLPAGENAME}}]]

Latest revision as of 20:27, 29 October 2022

Dermagraft.png

Dermagraft-TC is an artifical skin created from harvested foreskins from infant circumcision.[1] It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is FDA approved,[2][3] and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.[4]

References

  1. REFweb Dermagraft-TC: Overview, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
    Quote: Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
  2. REFweb Dermagraft-TC, MediLexicon. Retrieved 6 March 2011.
    Quote: ...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
  3. REFnews (28 March 2007)."Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA", Transplant News. Retrieved 6 March 2011.
    Quote: ...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
  4. REFjournal Daecher M. Circumcision. Icon. 1998; 2(2): 70-73.